Phadia's (now Thermo Fisher Scientific) autoimmunity tests allow identification of pathogenic autoantibodies already in the early stages of the disease. This is important as an early diagnosis and subsequent treatment potentially inhibit the irreversible damage of the progressive autoimmune disease.
Approximately 20 fully automated EliA and 30 Varelisa tests are currently available and the number of new tests is steadily increasing. The tests detect autoantibodies of high diagnostic value for different autoimmune conditions such as rheumatoid arthritis, connective tissue diseases, celiac disease and others.
In addition to the high number of autoimmunity tests, we offer reliable and fully automated instruments to ensure delivery of accurate and reproducible test results.